Gene · 316
Papers2,549
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,549
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Improved clearance predictions for aldehyde oxidase substrates using a novel triculture human hepatocyte model. | Drug Metab Dispos | 2025 | 40147225 | PubTator, text mining | PubMed |
| Early postnatal hepatocyte transplantation in a child with molybdenum cofactor deficiency type B. | Mol Genet Metab | 2025 | 40121797 | PubTator, text mining | PubMed |
| Variability in intestinal drug metabolizing enzymes and transporters in Crohn's disease and potential impact on oral drug absorption. | Br J Clin Pharmacol | 2025 | 40040248 | PubTator, text mining | PubMed |
| Is N1-Methylnicotinamide a Good Organic Cation Transporter 2 (OCT2) Biomarker? | Metabolites | 2025 | 39997705 | PubTator, text mining | PubMed |
| HepG2 cells do not express xanthine oxidoreductase (XOR): Implications for XOR and uric acid-related research. | Free Radic Biol Med | 2025 | 39988063 | PubTator, text mining | PubMed |
| Interactions between NAD+ metabolism and immune cell infiltration in ulcerative colitis: subtype identification and development of novel diagnostic models. | Front Immunol | 2025 | 39975557 | PubTator, text mining | PubMed |
| Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases. | Nat Commun | 2025 | 39971927 | PubTator, text mining | PubMed |
| Analysis of microarray and single-cell RNA-seq identifies gene co-expression, cell-cell communication, and tumor environment associated with metabolite interconversion enzyme in prostate cancer. | Discov Oncol | 2025 | 39946051 | PubTator, text mining | PubMed |
| Analysing DNA methylation and transcriptomic signatures to predict prostate cancer recurrence risk. | Discov Oncol | 2025 | 39893332 | PubTator, text mining | PubMed |
| Deciphering the Transcriptional Metabolic Profile of Adipose-Derived Stem Cells During Osteogenic Differentiation and Epigenetic Drug Treatment. | Cells | 2025 | 39851564 | PubTator, text mining | PubMed |
| Comprehensive analysis of protein post-translational modifications reveals PTPN2-STAT1-AOX axis-mediated tumor progression in hepatocellular carcinomas. | Transl Oncol | 2025 | 39837058 | PubTator, text mining | PubMed |
| Elucidating the Phase I metabolism of psilocin in vitro. | Arch Toxicol | 2025 | 39751877 | PubTator, text mining | PubMed |
| Identification of hsa_circ_0076957 and miR-4512-targeted COL19A1 as regulators in clopidogrel resistance among stable coronary heart disease patients through comprehensive circRNA and miRNA analysis. | Eur J Pharmacol | 2025 | 39615866 | PubTator, text mining | PubMed |
| Establishing a physiologically based pharmacokinetic framework for aldehyde oxidase and dual aldehyde oxidase-CYP substrates. | CPT Pharmacometrics Syst Pharmacol | 2025 | 39444174 | PubTator, text mining | PubMed |
| Eniluracil blocks AREG signalling-induced pro-inflammatory fibroblasts of melanoma in heart failure. | ESC Heart Fail | 2025 | 39364781 | PubTator, text mining | PubMed |
| Pharmacogenomic Assessment of Genes Implicated in Thiopurine Metabolism and Toxicity in a UK Cohort of Pediatric Patients With Inflammatory Bowel Disease. | Inflamm Bowel Dis | 2025 | 39011784 | PubTator, text mining | PubMed |
| Potential Molecular Markers for Cholecystic Inflammation-Induced Carcinogenesis Based on RNA-Seq Gene Screening. | Comb Chem High Throughput Screen | 2025 | 38716548 | PubTator, text mining | PubMed |
| Machine learning-based pan-cancer study of classification and mechanism of BRAF inhibitor resistance. | Transl Cancer Res | 2024 | 39816555 | PubTator, text mining | PubMed |
| G9a/DNMT1 co-targeting inhibits non-small cell lung cancer growth and reprograms tumor cells to respond to cancer-drugs through SCARA5 and AOX1. | Cell Death Dis | 2024 | 39488528 | PubTator, text mining | PubMed |
| Low level exposure to BDE-47 facilitates the development of prostate cancer through TOP2A/LDHA/lactylation positive feedback circuit. | Environ Res | 2024 | 39362459 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/316/papers?page=4